Martina Crysandt

Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With <i>FLT3</i>–Internal Tandem Duplication Mutation (SORMAIN)

Andreas Burchert, Gesine Bug, Lea Fritz et al. · Journal of Clinical Oncology · 2020 · 538 citations · Full text

Heterogeneous bone-marrow stromal progenitors drive myelofibrosis via a druggable alarmin axis

Nils B. Leimkühler, Hélène F.E. Gleitz, Ronghui Li et al. · Cell stem cell · 2020 · 162 citations · Full text

Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapy

Stefan Wilop, Sabine von Hobe, Martina Crysandt et al. · Journal of Cancer Research and Clinical Oncology · 2009 · 161 citations · Full text

Medicine, Pharmacology, Bronchial Neoplasm +8

Valproate and Retinoic Acid in Combination With Decitabine in Elderly Nonfit Patients With Acute Myeloid Leukemia: Results of a Multicenter, Randomized, 2 × 2, Phase II Trial

Michael Lübbert, Olga Grishina, Claudia Schmoor et al. · Journal of Clinical Oncology · 2019 · 88 citations

Randomized Comparison of Pazopanib and Doxorubicin as First-Line Treatment in Patients With Metastatic Soft Tissue Sarcoma Age 60 Years or Older: Results of a German Intergroup Study

Viktor Grünwald, Annika Karch, Markus K. Schuler et al. · Journal of Clinical Oncology · 2020 · 87 citations